Future research assessing the clinical utility of the serum IL-10/TNF-α ratio and other cytokine and cytokine ratios as systemic biomarkers capable of phenotypically differentiating the severity in knee osteoarthritis is warranted. The gene discussed is IL10; the disease is osteoarthritis, knee.